CDKN2A and ovarian serous tumor: Non-serous ovarian tumors, including clear cell, endometrioid, and mixed tumors, displayed similar patterns of expression of p16, p21, p27, and ki67 while serous ovarian tumors showed opposite expression patterns of the CDK inhibitors.